Abstract
Background: Diagnosis of chronic low back pain (CLBP) is traditionally predicated on identifying under- lying pathological or anatomical causes, with treatment outcomes modest at best. Alternately, it is sug- gested that identification of underlying pain mechanisms with treatments targeted towards specific pain phenotypes may yield more success. Differentiation between nociceptive and neuropathic components of CLBP is problematic; evidence suggests that clinicians fail to identify a significant neuropathic component in many CLBP patients. The painDETECT questionnaire (PDQ) was specifically developed to identify occult but significant neuropathic components in individuals thought to have predominantly nociceptive pain.
Methods: Using the PDQ, we classified 50 CLBP patients into two distinct groups; those with predomi- nantly nociceptive pain (Group 1) and those with a significant neuropathic component (Group 2). We characterised these two distinct CLBP sub-groups using a) questionnaire-based behavioural evaluation measuring pain-related function and quality of life, pain intensity and psychological well-being and b) sensory examination, using two-point and tactile threshold discrimination.
Objective: We sought to determine if differences in the pain phenotype of each CLBP sub-group would be reflected in sensory and behavioural group profiles.
Results: We report that Group 1 and Group 2 sub-groups demonstrate unique clinical profiles with significant differences in sensory tactile discrimination thresholds and in a wide range of behavioural domains measuring pain intensity, disability and psychological well-being.
Conclusion: We have demonstrated distinct clinical profiles for CLBP patient sub-groups classified by PDQ. Our results give diagnostic confidence in using the PDQ to characterise two distinct pain pheno- types in a heterogeneous CLBP population.
Methods: Using the PDQ, we classified 50 CLBP patients into two distinct groups; those with predomi- nantly nociceptive pain (Group 1) and those with a significant neuropathic component (Group 2). We characterised these two distinct CLBP sub-groups using a) questionnaire-based behavioural evaluation measuring pain-related function and quality of life, pain intensity and psychological well-being and b) sensory examination, using two-point and tactile threshold discrimination.
Objective: We sought to determine if differences in the pain phenotype of each CLBP sub-group would be reflected in sensory and behavioural group profiles.
Results: We report that Group 1 and Group 2 sub-groups demonstrate unique clinical profiles with significant differences in sensory tactile discrimination thresholds and in a wide range of behavioural domains measuring pain intensity, disability and psychological well-being.
Conclusion: We have demonstrated distinct clinical profiles for CLBP patient sub-groups classified by PDQ. Our results give diagnostic confidence in using the PDQ to characterise two distinct pain pheno- types in a heterogeneous CLBP population.
Original language | English |
---|---|
Pages (from-to) | 40-48 |
Number of pages | 9 |
Journal | Musculoskeletal Science and Practice |
Volume | 27 |
Early online date | 19 Dec 2016 |
DOIs | |
Publication status | Published - 1 Feb 2017 |
Keywords
- Chronic pain
- Low back pain
- Neuropathic pain
- Nociceptive pain